TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations.

Elio Adib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.